Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Lotus Pharmaceutical (1795 TT)
Watchlist
41
Analysis
Health Care
•
Taiwan
Lotus Pharmaceutical Co., Ltd. manufactures and distributes oral medicine, ointment and injection medicine.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Lotus Pharmaceutical
•
21 Mar 2024 09:30
Lotus Pharmaceutical (1795 TT): Record-High Performance in 2023; What Lies Ahead?
Lotus achieved 16% and 36%, YoY, revenue and profit growth, respectively, in 2023. The company is facing slight revenue decline in early 2024,...
Tina Banerjee
Follow
483 Views
Share
bearish
•
Quantitative Analysis
•
03 Mar 2024 10:00
TWSE Short Interest Weekly (Mar 1st): Wiwynn, Lite-On Tech, TSMC, Shihlin Elec&Eng, Evergreen Marine
We analyzed TWSE short interest report for the past week and highlighted short interest changes in Wiwynn, Lite-On Tech, TSMC, Shihlin Elec&Eng,...
Ke Yan, CFA, FRM
Follow
549 Views
Share
bullish
•
Quantitative Analysis
•
02 Jan 2024 06:00
TWSE Short Interest Weekly (Dec 29th): Short Covering Towards Year End
We analyzed TWSE short interest report for the past week and highlight short interest changes in Acer, China Airlines, Chung-Hsin, Quanta Computer,...
Ke Yan, CFA, FRM
Follow
545 Views
Share
bearish
•
Quantitative Analysis
•
17 Dec 2023 10:00
TWSE Short Interest Weekly (Dec 15th): Gigabyte Tech, Novatek, Faraday Tech, Quanta Computer
We analyzed TWSE short interest report for the past week and highlight short interest changes in Gigabyte Tech, Novatek, Faraday Tech, Quanta...
Ke Yan, CFA, FRM
Follow
541 Views
Share
bearish
•
Quantitative Analysis
•
29 Oct 2023 10:00
TWSE Short Interest Weekly (Oct 27th): Nan Ya Printed, Asmedia Tech, Global Unichip, TSMC
We analyzed TWSE short interest report for the past week and highlight short interest changes in Nan Ya Printed, Asmedia Tech, Global Unichip, TSMC.
Ke Yan, CFA, FRM
Follow
595 Views
Share
First
Previous
2
3
4
5
6
7
8
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x